GGrantIndex
Sort

39,280 grants matching leukemia

Growth Factor Imaging and Photoimmunotherapy

$1,926,705
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Studies of Occupational Cancer

$1,924,083
Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Childhood Cancer Gene Program Project Grant

$1,923,795
St. Jude Children'S Research Hospital · P01 · FY2005 · CA

Protein Structure

$1,923,299
Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,922,731
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Defining the Role of DNA Rereplication of Chromosome 21 in the Development and Pathophysiology of Down Syndrome

$1,918,500
Joshua Cranston Black · University Of Colorado Denver · R01 · FY2021 · AI

Quantitative and functional characterization of therapeutic resistance in cancer

$1,918,173
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2019 · CA

Enhancing T Cell Therapy of Cancer

$1,916,364
Helen E Heslop · Baylor College Of Medicine · P01 · FY2012 · CA

Biology and Transplantation of the Hematopoietic Stem Cell

$1,914,901
John E Wagner · University Of Minnesota · P01 · FY2016 · CA

Biology and Transplantation of the Hematopoietic Stem Cell

$1,914,865
John E Wagner · University Of Minnesota · P01 · FY2017 · CA

Biology and Transplantation of the Hematopoietic Stem Cell

$1,914,832
John E Wagner · University Of Minnesota · P01 · FY2018 · CA

Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma

$1,913,660
Lisa Rimsza · Mayo Clinic Arizona · P01 · FY2022 · CA

Mixed Hematopoietic Chimerism After Stem Cell Allografts

$1,909,574
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2012 · CA

Mixed Hematopoietic Chimerism After Stem Cell Allografts

$1,909,490
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA

IL-2:IL-15 : implications for cancer therapy (Investigator -Initiated Project)

$1,906,642
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Southeast Cancer Control Consortium, Inc

$1,906,536
James Norman Atkins · Southeast Clinical Oncol Res Consortium · U10 · FY2008 · CA

Studies of Populations Exposed to Occupational Sources of Radiation

$1,906,180
Martha S Linet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

Clinical Research Correlatives Core

$1,904,916
Kaska Wloka · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

THERAPY OF CML

$1,903,897
University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA

Molecular Pathways to Thymic Lymphoma and Leukemia

$1,903,674
Dana-Farber Cancer Institute · P01 · FY2004 · CA

DEVELOPMENT OF NEW ANTITUMOR AGENTS

$1,903,019
Southern Research Institute · P01 · FY2000 · CA

GVL without GVHD across HLA barriers: Translational Studies

$1,902,623
Megan Sykes · Massachusetts General Hospital · P01 · FY2009 · CA

Hematopoietic Stem Cells for Transplantation

$1,901,671
Curt I Civin · Johns Hopkins University · P01 · FY2006 · CA

Center for Solutions for ME/CFS

$1,900,660
W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2020 · AI

Drug Combination Signatures for Prediction and Mitigation of Toxicity

$1,899,685
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · HG